ABSTRACT
In the presence of active trophoblastic disease, UK studies have shown that chemotherapy for choriocarcinoma is more often required among women given COCs. This has not been shown in studies from the US, probably because chemotherapy there is given to almost all cases of trophoblastic disease, thereby obliterating any hormonal effect.
